The short version of freeze-thaw cycle fits in a sentence. The long version — which is the one that helps — is below.
This page was last updated on 2026-04-09 and is reviewed periodically as new material appears.
Identity and purity are established with complementary methods rather than one test. Reverse-phase high-performance liquid chromatography separates the main peak from deletion sequences and oxidized variants, and its area percentage is the usual purity figure. Mass spectrometry confirms the expected molecular mass and can flag truncations or modifications that chromatography alone might miss. Amino acid analysis and peptide mapping add sequence-level confirmation, while residual counter-ion and water content are measured separately.
A freeze-dried sample is generally the most stable form and is commonly held at minus twenty degrees Celsius or lower for long-term keeping, with brief transfers at room temperature. The solid is hygroscopic, so vials are warmed to ambient temperature before opening to prevent condensation from degrading the contents. Light exposure and repeated temperature cycling are both avoided in routine handling. Storage over a desiccant is a common laboratory practice that limits moisture uptake during repeated access.
Once dissolved, the material is considerably less stable than the dry solid. Aqueous solutions are usually kept cold and used within a short window, and neutral or mildly acidic buffers are preferred over strongly alkaline conditions. Freeze-thaw cycles promote aggregation and loss of material to container surfaces, so dividing a batch into single-use aliquots is standard. Adsorption to plastic and glass can lower the measured concentration, meaning solution strength may need rechecking before an experiment.
Terminology in the literature is not fully standardised. Papers and product listings use BPC-157, BPC 157, and the longer phrase stable gastric pentadecapeptide BPC 157 interchangeably, and synonyms such as bepecin or PL 14736 appear in older or company-linked publications. Purity claims and reported masses can also differ between sources because peptide preparations may include counterions, residual solvents, or bound water. This variability complicates direct comparison of results across studies and makes the exact identity and grade of a given sample worth verifying. Discussions of the compound should therefore specify the source, salt form, and stated purity where those are known.
BPC-157 is a synthetic peptide composed of fifteen amino acid residues, with the sequence Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val. Its name derives from body protection compound, a term used for a protein fraction identified in human gastric juice. Researchers in Zagreb first reported the pentadecapeptide in the early 1990s and described it as a stable fragment of that larger protein. The compound is also catalogued as PL 14736 and, in some commercial contexts, as bepecin. Its molecular formula is C62H98N16O22 and its monoisotopic mass is approximately 1419 daltons.
| Property | Value | Notes |
|---|---|---|
| Dry powder storage | -20 °C or below | Desiccated and protected from light |
| Solution storage | 2-8 °C, short term | Aliquot to avoid freeze-thaw cycling |
| Reconstitution solvent | Water or buffered saline | Near-neutral pH is generally preferred |
| Identity confirmation | Mass spectrometry | Matches expected monoisotopic mass |
| Purity assessment | Reverse-phase HPLC | Reported as main-peak area percentage |
Some properties, such as the peptide's sequence and molecular mass, are firmly established. Other claims, particularly about mechanism and clinical benefit, remain open questions. Proposed mechanisms include effects on nitric oxide signaling and on cell migration, but these are hypotheses supported by limited evidence. Reviewers often note that the field lacks large controlled human trials. Positive animal findings are best treated as signals for further study rather than as settled conclusions.
Most published studies examine BPC-157 in animal models rather than in humans. Common subjects include rats and mice, and researchers often use models of tissue injury, surgery, or induced inflammation. Reported endpoints include healing rates, blood vessel formation, and markers of tissue repair. These designs provide controlled comparisons, but findings in animals do not automatically transfer to people. Human clinical data remain limited and are frequently described as preliminary.
Doses in the literature are usually expressed in micrograms or nanograms per kilogram of body weight. Investigators have administered the peptide by several routes, including injection and oral delivery, depending on the question asked. Route and dose vary widely across studies, which complicates direct comparison of results. Many papers report effects at low doses, but the absence of a standardized protocol limits generalization. Reporting practice differs between research groups.
Within the research literature, the peptide is discussed through several provisional mechanisms, including cytoprotection, modulation of growth factor signaling, and interaction with the nitric oxide system. None of these mechanisms is fully characterized, and no single pathway is universally accepted. Review articles typically note the gap between consistent animal findings and sparse human evidence. The compound is classified as a research chemical rather than an approved pharmaceutical, which shapes how studies are designed, funded, and reported.
BPC-157 is a synthetic pentadecapeptide with the sequence GEPPPGKPADDAGLV, corresponding to a partial fragment of a larger protein detected in human gastric juice. The name derives from the parent protein designation BPC, an abbreviation of body protection compound, with 157 acting as a fraction or batch identifier used by the original investigators. Its molecular weight is approximately 1419 daltons, and the chain contains no unusual residues or disulfide bridges. In the literature it is described as a short, water-soluble fragment rather than a complete natural protein.
Most early work on this peptide originated in the 1990s from a research group in Zagreb, Croatia, relying on animal models and cell cultures. Reported observations included effects on gastrointestinal lesion healing, tendon fibroblast migration, and blood vessel formation under controlled laboratory conditions. These findings come predominantly from rodent studies and in vitro assays rather than from human trials. Controlled human data remain limited, and the degree to which animal results translate to human physiology is an open question rather than a settled fact.
A vaccine to remove senescent cells, a key driver of the aging process, is demonstrated in mice by researchers from Japan. The American biotechnology company Altos Labs, which focuses on life extension research, is founded.
upregulation Also promotion. Any process, natural or artificial, which increases the level of gene expression of a certain gene. A gene which is observed to be expressed at relatively high levels (such as by detecting higher levels of its mRNA transcripts) in one sample compared to another sample is said to be upregulated. Contrast downregulation.
=== Biosensing === SWCNTs have nanoscale dimensions that match the size of biological species. Due to this size compatibility and their large surface-to-volume ratio, they are sensitive to changes in their chemical environment. Through covalent and non-covalent surface functionalization, SWCNTs can be precisely tailored for selective molecular interactions with a target analyte. The SWCNT represents the transduction unit that converts the interaction into a signal change (optical or electrical). Due to continuous progress in the development of detection strategies, there are numerous examples of the use of SWCNTs as highly sensitive nanosensors (even down to the single molecule level) for a variety of important biomolecules. Examples include the detection of reactive oxygen and nitrogen species, neurotransmitters, other small molecules, lipids, proteins, sugars, DNA/RNA, enzymes as well as bacteria.
The headquarters of the Swiss charity Mine Action FSD, in Kharkiv, was struck by a Russian ballistic missile. The Ukrainian 79th Tavrian Air Assault Brigade claimed to have repelled a major Russian assault on Kurakhove, inflicting losses of 12 motorcycles destroyed, six tanks and seven armoured vehicles damaged, 40 Russian soldiers killed and 37 others injured. Ukrainian media reported that the HUR carried out a cyberattack on several banks operating in Russia and other financial institutions in the country. Ukrainian soldiers of the "Khortytsia" group, based in Kharkiv, shot other Ukrainian soldiers due to "personal" issues, killing three soldiers and wounding four. A GRU officer and his wife were injured in a car bombing in Moscow. The Ukrainians claimed that Russian losses in Vovchansk include the 138th Separate Guards Motor Rifle Brigade, the 83rd Tank Regiment and the 157th Tank Regiment. According to Vitaly Sarantsev, spokesman for Ukraine’s operational-tactical group Kharkiv, "the staff number of motorized rifle brigades in the Russian Federation is up to 5,000 personnel, and tank regiments have 94 units of equipment (tanks)". He claimed that Russian losses (killed, wounded, or captured) for "roughly a division's worth of personnel" were 91 percent.
Master of Science, Master of Business Administration, Master of Health Administration, Doctor of medical laboratory science for specialization, education and management roles. Doctor of Philosophy for management and directorship roles in the clinical laboratory as well as for academic research and professorship. Doctors of Philosophy holding a degree in a biological science, and who are board certified by a CLIA-approved entity, are qualified as a medical laboratory director. Doctor of Medicine or Doctor of clinical laboratory Science - this is the position that qualifies an individual to oversee or direct almost all types of clinical laboratories. Under U.S. CLIA laws, a requirement of at least year of clinical laboratory experience (any MD) or pathology residency must be met. In the United Kingdom the Modernising Scientific Careers (MSC) programme sets out a training and career framework for the healthcare science workforce. One aspect of the framework was the formalisation of training to develop talented clinical scientists to undertake Higher Specialist Scientist Training (HSST) programmes to prepare them for roles as consultant clinical scientists. Training through the Higher Specialist Scientist Training pathway is discipline specific. For life science disciplines (immunology, microbiology, virology, haematology, biochemistry) the training curriculum and formal examinations are administered by the Royal College of Pathologists.
Sources: en.wikipedia.org
S. divinorum (0.89 mg/g to 3.70 mg/g). S. recognita (212.9 μg/g). S. cryptantha (51.5 μg/g). S. glutinosa (38.9 μg/g). Salvinorin B has been detected in S. potentillifolia and S. adenocaulon, however these species do not contain a measureable amount of salvinorin A.
=== Discovery and development === The patent for Vicoprofen was filed in December 1984, and US patent number 4,587,252 was granted in May 1986. Although ibuprofen and hydrocodone were already available on the market at this time, the fact that they had never been supplied together in a single formulation required approval from the FDA as if it were a new drug. Knoll filed an investigational new drug application on 30 December 1986. A new drug application was later filed by Knoll on 25 April 1996, and received final approval from the FDA on 23 September 1997. Vicoprofen tablets were initially formulated and packaged by Knoll, with ibuprofen supplied by Albemarle Corporation and hydrocodone supplied by Mallinckrodt Pharmaceuticals. The validity of Knoll's patent on Vicoprofen has been challenged in federal court. In September 2002, the US District Court for the Northern District of Illinois granted a motion of invalidity filed by Teva Pharmaceuticals against Knoll's patent on Vicoprofen, ruling the patent was invalid as obvious. This ruling paved the way for Teva's abbreviated new drug application to be approved by the FDA which would allow them to manufacture and market their own generic. Knoll appealed the decision. In April 2003, Teva announced that its abbreviated new drug application had been approved by the FDA, and its generic would begin shipping immediately.
== History == Pacinian corpuscles were the first cellular sensory receptor ever observed. They were first reported by German anatomist and botanist Abraham Vater and his student Johannes Gottlieb Lehmann in 1741, but ultimately named after Italian anatomist Filippo Pacini, who rediscovered them in 1835. John Shekleton, a curator of the Royal College of Surgeons in Ireland, also discovered them before Pacini, but his results were published later. Similar to Pacinian corpuscles, Herbst corpuscles and Grandry corpuscles are found in bird species.
==== Variable phenomena – dependently arisen processes ==== The principle of conditionality, which is real and stable, is contrasted with the "dependently arisen processes", which are described as "impermanent, conditioned, dependently arisen, of a nature to be destroyed, of a nature to vanish, of a nature to fade away, of a nature to cease." SA 296 describes them simply as "arising thus according to causal condition, these are called dharmas arisen by causal condition."
Clonidine, sold under the brand names Catapres and Kapvay, among others, is an α2-adrenergic receptor agonist, hypotensive, sedative and anxiolytic drug used to treat high blood pressure, attention deficit hyperactivity disorder, perioperative pain, drug withdrawal (e.g., alcohol, opioids, or nicotine), and menopausal flushing. Clonidine is sometimes prescribed off-label for tics. It is used orally (by mouth), by injection, or as a transdermal skin patch. Onset of action is typically within an hour with the effects on blood pressure lasting for up to eight hours. Xylazine is a structural analog of clonidine. Common side effects include dry mouth, dizziness, headaches, hypotension, and sleepiness. Severe side effects may include hallucinations, heart arrhythmias, and confusion. If rapidly stopped, withdrawal effects may occur, such as a dangerous rise in blood pressure. Use during pregnancy or breastfeeding is not recommended. Clonidine lowers blood pressure by stimulating α2-adrenergic receptors and imidazoline receptors in the brain, which results in relaxation of many arteries. Clonidine was patented in 1961 and came into medical use in 1966. It is available as a generic medication. In 2023, it was the 82nd most commonly prescribed medication in the United States, with more than 8 million prescriptions.
Sources: en.wikipedia.org
Given the wide range of bacterial, viral, fungal, protozoal, and helminthic pathogens that cause debilitating and life-threatening illnesses, the ability to quickly identify the cause of infection is important yet often challenging. For example, more than half of cases of encephalitis, a severe illness affecting the brain, remain undiagnosed, despite extensive testing using the standard of care (microbiological culture) and state-of-the-art clinical laboratory methods. Metagenomic sequencing-based diagnostic tests are currently being developed for clinical use and show promise as a sensitive, specific, and rapid way to diagnose infection using a single all-encompassing test. This test is similar to current PCR tests; however, an untargeted whole genome amplification is used rather than primers for a specific infectious agent. This amplification step is followed by next-generation sequencing or third-generation sequencing, alignment comparisons, and taxonomic classification using large databases of thousands of pathogen and commensal reference genomes. Simultaneously, antimicrobial resistance genes within pathogen and plasmid genomes are sequenced and aligned to the taxonomically classified pathogen genomes to generate an antimicrobial resistance profile – analogous to antibiotic sensitivity testing – to facilitate antimicrobial stewardship and allow for the optimization of treatment using the most effective drugs for a patient's infection. Metagenomic sequencing could prove especially useful for diagnosis when the patient is immunocompromised.
=== Bosnian War === Hitchens cited the Bosnian War as monumentally changing his views on military intervention, commenting that for the first time he found himself on the side of neoconservatives. In an interview with Johann Hari he said:
=== Wound dehiscence === The rates of a surgical wound opening after surgery has remained constant. When a wound opens after surgery, the hospital stay becomes longer and the medical care becomes more intensive if a surgical wound opens after surgery.
=== ISCEA Expansion into Latin America === In 2006 Seguro Popular, a governmental health-care institution created in 2002; issued an RFID technology mandate to authenticate and improve drug safety within its supply chain. ISCEA served as RFID technical advisor to the Mexican government providing guidance on best practices to implement RFID technology in Seguro Popular's Supply Chain Model, and also providing with RFID Supply Chain Manager (RFIDSCM) certification to Mexican Pharma Manufacturers and Distributors looking to comply with the mandate. Seguro Popular was later replaced by Insabi during the administration of President Andrés Manuel López Obrador, but ISCEA's presence has been expanding in Mexico and other Latin American countries ever since. ISCEA has been active in the region through partnerships with Universities and Associations, delivering awards, participating in supply chain events and contributing with articles to supply chain media in Mexico,
In a 1990 interview, Freeman said that Glory was one of his favorite releases—"The Black legacy is as noble, is as heroic, is as filled with adventure and conquest and discovery as anybody else's. It's just that nobody knows it." In 1990, Freeman provided the voice of Frederick Douglass in The Civil War, a television miniseries about the American Civil War. In the same year he played a key role in the critically panned The Bonfire of the Vanities. According to the review aggregate site Rotten Tomatoes, the film has an approval rating of 16% based on 51 reviews. In the summer of 1990, he played Petruchio, a role he had been thinking about for six years, in Shakespeare's The Taming of the Shrew, which opened at Delacorte theater in New York City. "[Petruchio] seems to have a lot of fun in life", he said. In 1991, Freeman had a supporting role in Robin Hood: Prince of Thieves, an action-adventure starring Kevin Costner. The film was a commercial success, but garnered mixed reviews from critics; The New York Times' Vincent Canby thought Freeman played Azeem with "wit and humor" despite the "muddled" plot.
Sources: en.wikipedia.org
Low temperature slows the chemical reactions, such as oxidation and hydrolysis, that break down a peptide chain. Water and oxygen are the main drivers of degradation, so a cold and dry environment extends usable life. Actual shelf life depends on the batch, the salt form, and the container.
It normally reports the share of the chromatographic signal that belongs to the main peak, not a measure of activity. A high figure means few related substances were detected under the stated method and wavelength. Different laboratories and methods can return different values for the same material.
Retention time alone is weak evidence, because unrelated peptides can elute at similar positions. Amino acid analysis or peptide mapping gives stronger sequence information when a mass spectrometer is unavailable. Most laboratories still treat mass confirmation as the standard step for verifying the correct compound.
BPC-157 is a synthetic fifteen-amino-acid peptide whose sequence corresponds to a fragment of a protein found in human gastric juice. It is studied mainly in preclinical research and is not an approved pharmaceutical product in major markets. Materials sold for laboratory use are typically labelled as research chemicals.